<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Clinical research / Food and Drug Administration / Drug discovery / Pharmaceutical industry / Off-label use / Orphan drug / Orphan Drug Act / Clinical trial / Pharmacology / Pharmaceutical sciences / Health
Date: 2005-11-11 06:22:18
Pharmaceuticals policy
Clinical research
Food and Drug Administration
Drug discovery
Pharmaceutical industry
Off-label use
Orphan drug
Orphan Drug Act
Clinical trial
Pharmacology
Pharmaceutical sciences
Health

http://pqasb.pqarchiver.com/washingtonposthtml?MAC=b

Add to Reading List

Source URL: lansbury.bwh.harvard.edu

Download Document from Source Website

File Size: 79,44 KB

Share Document on Facebook

Similar Documents

House of Commons Health Committee The Influence of the Pharmaceutical Industry

DocID: 1v3YA - View Document

Speakers Confirmed BD Biosciences Industry Days A roadshow of talks specifically tailored to those working in the biotechnology, clinical research and pharmaceutical industry. Join leaders in the field and BD experts for

DocID: 1uWLK - View Document

NEWS RELEASE Copley Scientific celebrates seven decades of responsive service to the pharmaceutical industry 17th May 2016: Nottingham, UK: Copley Scientific, a family-owned company that began supplying glassware to the

DocID: 1utWK - View Document

2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany

DocID: 1utU5 - View Document

Index of abbreviations AAMC – Australian Army Medical Corps AB – Artium Baccalaureus, Bachelor of Arts Aberd – Aberdeen ABPI – Association of the British Pharmaceutical Industry AC – Companion, Order of Austral

DocID: 1ushC - View Document